CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03355794
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:50.717723+00:00
Published At: 2023-01-13T00:00:00+00:00
Record Updated At: 2023-01-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Diffuse Intrinsic Pontine Glioma", "Malignant Glioma of Brain", "High Grade Glioma", "Bithalamic High Grade Glioma", "Brainstem Glioma", "Glioblastoma", "Anaplastic Astrocytoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-01-13"
protocolSection.identificationModule.nctId: "NCT03355794"
protocolSection.identificationModule.officialTitle: "A Phase I Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.